Homozygous deleterious variants in the C‐terminal of TDRD5 impair spermiogenesis, causing severe oligoasthenoteratozoospermia in humans
Andrology · 2025-07 · 13 (5) · 1270-1284
DOI: 10.1111/andr.13676 ↗Kurz gefasst
Fachartikel in der Zeitschrift Andrology, online erschienen am 07.06.2024. Verfasst von Rui Guo und 15 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract, Anhui Medical University, Hefei, Anhui, China. Hauptthemen laut MEDLINE: Oligospermia, Spermatogenesis, Asthenozoospermia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Anhui Province, Basic and Clinical Cooperative Research Promotion Program of Anhui Medical University.
Abstract (Originalsprache)
Background
PiRNA pathway factors, including evolutionarily conserved Tudor domain‐containing proteins, play crucial roles in suppressing transposons and regulating post‐meiotic gene expression. TDRD5 is essential for retrotransposon silencing and pachytene piRNA biogenesis; however, a causal link between TDRD5 variants and human infertility has not yet been established.
Objective
To identify the likely pathogenic variants of TDRD5 in infertile men, characterised by azoospermia or severe oligozoospermia. Material and methods Potential candidate variants were identified and confirmed using whole‐exome and Sanger sequencing. Haematoxylin and eosin staining, immunofluorescence, and ultrastructural analyses were performed to investigate the structural and functional abnormalities of spermatozoa. The pathogenicity of the identified TDRD5 variants was verified using in vitro experiments. Functional effects of the C‐terminal nonsense variant were assessed via histology, immunofluorescence staining, and small‐RNA sequencing. Intracytoplasmic sperm injection (ICSI) was also performed to evaluate the efficacy of the clinical treatment.
Results
We identified a homozygous missense variant (c.3043G > A, p.A1015T) and a homozygous nonsense variant (c.2293G > T, p.E765*) of TDRD5 in two unrelated infertile men. Both patients exhibited severe oligoasthenoteratozoospermia, characterised by the presence of spermatozoa with multiple heads and/or flagella, as well as acrosomal hypoplasia. In vitro experiments revealed that the p.A1015T variant caused a diffuse distribution of TDRD5 granules, whereas the p.E765* variant led to the production of a C‐terminal truncated protein with nuclear localisation, instead of the typical cytoplasmic localisation observed for the wild‐type protein. Functional investigations also revealed that truncation of the C‐terminal region of TDRD5 could potentially lead to a decline in the expression levels of intermitochondrial cement and chromatoid body components, such as MIWI (PIWIL1) and UPF1, and a slight decrease in the abundance of pachytene piRNA, ultimately resulting in compromised spermiogenesis. ICSI may be an effective treatment for these deficiencies. Discussion and conclusion This study implicates TDRD5 as a novel candidate gene in the pathogenesis of human male infertility, emphasising the contribution of piRNA pathway genes to male infertility. In addition, our data suggest that ICSI could be a promising treatment for infertile men harbouring TDRD5 variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract, Anhui Medical University, Hefei, Anhui, China.
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
- Department of Obstetrics and Gynecology, Reproductive Medicine Center, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
- Institute for Fetology, The First Affiliated Hospital of Soochow University, Suzhou, China.
- State Key Laboratory of Reproductive Medicine, Department of Histology and Embryology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
- State Key Laboratory of Reproductive Medicine, The Center for Clinical Reproductive Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Anhui Province
- Basic and Clinical Cooperative Research Promotion Program of Anhui Medical University
- National Key R&D Program of China
- Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
- the Research Fund of Anhui Institute of Translational Medicine
- National Key Research and Development Program of China
Zitieren
APA
Guo, R., Ding, B., Hu, K., Wang, K., Tang, D., Wang, X., Sun, J., Li, K., Cheng, H., Xu, C., Sun, M., Lu, L., Liu, M., Cao, Y., Yang, X., & He, X. (2025). Homozygous deleterious variants in the C‐terminal of TDRD5 impair spermiogenesis, causing severe oligoasthenoteratozoospermia in humans. Andrology, 13(5), 1270-1284. https://doi.org/10.1111/andr.13676
Vancouver
Guo R, Ding B, Hu K, Wang K, Tang D, Wang X, et al. Homozygous deleterious variants in the C‐terminal of TDRD5 impair spermiogenesis, causing severe oligoasthenoteratozoospermia in humans. Andrology. 2025;13(5):1270-1284. doi:10.1111/andr.13676
BibTeX
@article{Guo2025,
author = {Guo, Rui and Ding, Biao and Hu, Kaiqin and Wang, Kai and Tang, Dongdong and Wang, Xuegu and Sun, Junpei and Li, KuoKuo and Cheng, Huiru and Xu, Chuan and Sun, Miao and Lu, Likui and Liu, Mingxi and Cao, Yunxia and Yang, Xiaoyu and He, Xiaojin},
title = {Homozygous deleterious variants in the C‐terminal of TDRD5 impair spermiogenesis, causing severe oligoasthenoteratozoospermia in humans},
journal = {Andrology},
year = {2025},
volume = {13},
number = {5},
pages = {1270--1284},
doi = {10.1111/andr.13676}
}
EUVIMED